3-37025665-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_001354624.2(MLH1):​c.-8C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000566 in 1,589,022 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0000071 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

MLH1
NM_001354624.2 5_prime_UTR_premature_start_codon_gain

Scores

2
11
5

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 3.53

Publications

3 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001354624.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.1067C>Tp.Ser356Phe
missense
Exon 12 of 19NP_000240.1
MLH1
NM_001354624.2
c.-8C>T
5_prime_UTR_premature_start_codon_gain
Exon 10 of 17NP_001341553.1
MLH1
NM_001354625.2
c.-8C>T
5_prime_UTR_premature_start_codon_gain
Exon 9 of 16NP_001341554.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.1067C>Tp.Ser356Phe
missense
Exon 12 of 19ENSP00000231790.3
MLH1
ENST00000456676.7
TSL:1
c.1067C>Tp.Ser356Phe
missense
Exon 12 of 17ENSP00000416687.3
MLH1
ENST00000413740.2
TSL:1
c.1067C>Tp.Ser356Phe
missense
Exon 12 of 15ENSP00000416476.2

Frequencies

GnomAD3 genomes
AF:
0.00000707
AC:
1
AN:
141478
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000268
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000553
AC:
8
AN:
1447544
Hom.:
0
Cov.:
34
AF XY:
0.00000695
AC XY:
5
AN XY:
719838
show subpopulations
African (AFR)
AF:
0.0000302
AC:
1
AN:
33074
American (AMR)
AF:
0.00
AC:
0
AN:
44212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25734
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38926
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85090
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52860
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.00000635
AC:
7
AN:
1102438
Other (OTH)
AF:
0.00
AC:
0
AN:
59566
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000707
AC:
1
AN:
141478
Hom.:
0
Cov.:
30
AF XY:
0.0000147
AC XY:
1
AN XY:
67840
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000268
AC:
1
AN:
37274
American (AMR)
AF:
0.00
AC:
0
AN:
13534
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3434
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4766
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4516
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8288
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
264
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66644
Other (OTH)
AF:
0.00
AC:
0
AN:
1858
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000464
Hom.:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Hereditary cancer-predisposing syndrome (2)
-
1
-
Breast and/or ovarian cancer (1)
-
1
-
Hereditary nonpolyposis colorectal neoplasms (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Pathogenic
0.29
D
BayesDel_noAF
Pathogenic
0.17
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Benign
0.67
D
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.044
D
MetaRNN
Uncertain
0.58
D
MetaSVM
Uncertain
0.18
D
MutationAssessor
Uncertain
2.3
M
PhyloP100
3.5
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.54
Sift
Uncertain
0.0090
D
Sift4G
Uncertain
0.017
D
Polyphen
0.44
B
Vest4
0.59
MutPred
0.44
Loss of glycosylation at S356 (P = 0.0163)
MVP
0.95
MPC
0.12
ClinPred
0.95
D
GERP RS
4.6
PromoterAI
0.0048
Neutral
Varity_R
0.13
gMVP
0.30
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs749334262; hg19: chr3-37067156; API